Market Research Report

Estrogen and Progestin Extended-Release Patches Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-17103
  • CAT ID : 7
  • Pages : 115
  • Date : Jun 2023
 

The global Estrogen and Progestin Extended-Release Patches market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Contraceptive Patch Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Estrogen and Progestin Extended-Release Patches include Mylan Pharmaceuticals Inc.(Viatris), Twirla, Novartis(HEXAL AG), Bayer Healthcare Pharmaceuticals, Noven, AbbVie, Hisamitsu Pharmaceutical Co., Inc., Watson Pharmaceuticals and Johnson & Johnson, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Estrogen and Progestin Extended-Release Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Estrogen and Progestin Extended-Release Patches. This report contains market size and forecasts of Estrogen and Progestin Extended-Release Patches in global, including the following market information:
Global Estrogen and Progestin Extended-Release Patches Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Estrogen and Progestin Extended-Release Patches Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Estrogen and Progestin Extended-Release Patches companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Estrogen and Progestin Extended-Release Patches manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Estrogen and Progestin Extended-Release Patches Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Estrogen and Progestin Extended-Release Patches Market Segment Percentages, by Type, 2022 (%)
Contraceptive Patch
Estradiol Patch
Others
Global Estrogen and Progestin Extended-Release Patches Market, by Sales Channel, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Estrogen and Progestin Extended-Release Patches Market Segment Percentages, by Sales Channel, 2022 (%)
Online Sales
Offline Sales
Global Estrogen and Progestin Extended-Release Patches Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Estrogen and Progestin Extended-Release Patches Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Estrogen and Progestin Extended-Release Patches revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Estrogen and Progestin Extended-Release Patches revenues share in global market, 2022 (%)
Key companies Estrogen and Progestin Extended-Release Patches sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Estrogen and Progestin Extended-Release Patches sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan Pharmaceuticals Inc.(Viatris)
Twirla
Novartis(HEXAL AG)
Bayer Healthcare Pharmaceuticals
Noven
AbbVie
Hisamitsu Pharmaceutical Co., Inc.
Watson Pharmaceuticals
Johnson & Johnson
ANI Pharmaceuticals
Zhejiang Yatai Pharmaceutical Company Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Estrogen and Progestin Extended-Release Patches, market overview.
Chapter 2: Global Estrogen and Progestin Extended-Release Patches market size in revenue and volume.
Chapter 3: Detailed analysis of Estrogen and Progestin Extended-Release Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by sales channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Estrogen and Progestin Extended-Release Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Estrogen and Progestin Extended-Release Patches capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Estrogen and Progestin Extended-Release Patches Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sales Channel
1.3 Global Estrogen and Progestin Extended-Release Patches Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Estrogen and Progestin Extended-Release Patches Overall Market Size
2.1 Global Estrogen and Progestin Extended-Release Patches Market Size: 2022 VS 2029
2.2 Global Estrogen and Progestin Extended-Release Patches Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Estrogen and Progestin Extended-Release Patches Sales: 2018-2029
3 Company Landscape
3.1 Top Estrogen and Progestin Extended-Release Patches Players in Global Market
3.2 Top Global Estrogen and Progestin Extended-Release Patches Companies Ranked by Revenue
3.3 Global Estrogen and Progestin Extended-Release Patches Revenue by Companies
3.4 Global Estrogen and Progestin Extended-Release Patches Sales by Companies
3.5 Global Estrogen and Progestin Extended-Release Patches Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Estrogen and Progestin Extended-Release Patches Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Estrogen and Progestin Extended-Release Patches Product Type
3.8 Tier 1, Tier 2 and Tier 3 Estrogen and Progestin Extended-Release Patches Players in Global Market
3.8.1 List of Global Tier 1 Estrogen and Progestin Extended-Release Patches Companies
3.8.2 List of Global Tier 2 and Tier 3 Estrogen and Progestin Extended-Release Patches Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Estrogen and Progestin Extended-Release Patches Market Size Markets, 2022 & 2029
4.1.2 Contraceptive Patch
4.1.3 Estradiol Patch
4.1.4 Others
4.2 By Type - Global Estrogen and Progestin Extended-Release Patches Revenue & Forecasts
4.2.1 By Type - Global Estrogen and Progestin Extended-Release Patches Revenue, 2018-2023
4.2.2 By Type - Global Estrogen and Progestin Extended-Release Patches Revenue, 2024-2029
4.2.3 By Type - Global Estrogen and Progestin Extended-Release Patches Revenue Market Share, 2018-2029
4.3 By Type - Global Estrogen and Progestin Extended-Release Patches Sales & Forecasts
4.3.1 By Type - Global Estrogen and Progestin Extended-Release Patches Sales, 2018-2023
4.3.2 By Type - Global Estrogen and Progestin Extended-Release Patches Sales, 2024-2029
4.3.3 By Type - Global Estrogen and Progestin Extended-Release Patches Sales Market Share, 2018-2029
4.4 By Type - Global Estrogen and Progestin Extended-Release Patches Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Sales Channel
5.1 Overview
5.1.1 By Sales Channel - Global Estrogen and Progestin Extended-Release Patches Market Size, 2022 & 2029
5.1.2 Online Sales
5.1.3 Offline Sales
5.2 By Sales Channel - Global Estrogen and Progestin Extended-Release Patches Revenue & Forecasts
5.2.1 By Sales Channel - Global Estrogen and Progestin Extended-Release Patches Revenue, 2018-2023
5.2.2 By Sales Channel - Global Estrogen and Progestin Extended-Release Patches Revenue, 2024-2029
5.2.3 By Sales Channel - Global Estrogen and Progestin Extended-Release Patches Revenue Market Share, 2018-2029
5.3 By Sales Channel - Global Estrogen and Progestin Extended-Release Patches Sales & Forecasts
5.3.1 By Sales Channel - Global Estrogen and Progestin Extended-Release Patches Sales, 2018-2023
5.3.2 By Sales Channel - Global Estrogen and Progestin Extended-Release Patches Sales, 2024-2029
5.3.3 By Sales Channel - Global Estrogen and Progestin Extended-Release Patches Sales Market Share, 2018-2029
5.4 By Sales Channel - Global Estrogen and Progestin Extended-Release Patches Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Estrogen and Progestin Extended-Release Patches Market Size, 2022 & 2029
6.2 By Region - Global Estrogen and Progestin Extended-Release Patches Revenue & Forecasts
6.2.1 By Region - Global Estrogen and Progestin Extended-Release Patches Revenue, 2018-2023
6.2.2 By Region - Global Estrogen and Progestin Extended-Release Patches Revenue, 2024-2029
6.2.3 By Region - Global Estrogen and Progestin Extended-Release Patches Revenue Market Share, 2018-2029
6.3 By Region - Global Estrogen and Progestin Extended-Release Patches Sales & Forecasts
6.3.1 By Region - Global Estrogen and Progestin Extended-Release Patches Sales, 2018-2023
6.3.2 By Region - Global Estrogen and Progestin Extended-Release Patches Sales, 2024-2029
6.3.3 By Region - Global Estrogen and Progestin Extended-Release Patches Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Estrogen and Progestin Extended-Release Patches Revenue, 2018-2029
6.4.2 By Country - North America Estrogen and Progestin Extended-Release Patches Sales, 2018-2029
6.4.3 US Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.4.4 Canada Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.4.5 Mexico Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Estrogen and Progestin Extended-Release Patches Revenue, 2018-2029
6.5.2 By Country - Europe Estrogen and Progestin Extended-Release Patches Sales, 2018-2029
6.5.3 Germany Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.5.4 France Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.5.5 U.K. Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.5.6 Italy Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.5.7 Russia Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.5.8 Nordic Countries Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.5.9 Benelux Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Estrogen and Progestin Extended-Release Patches Revenue, 2018-2029
6.6.2 By Region - Asia Estrogen and Progestin Extended-Release Patches Sales, 2018-2029
6.6.3 China Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.6.4 Japan Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.6.5 South Korea Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.6.6 Southeast Asia Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.6.7 India Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Estrogen and Progestin Extended-Release Patches Revenue, 2018-2029
6.7.2 By Country - South America Estrogen and Progestin Extended-Release Patches Sales, 2018-2029
6.7.3 Brazil Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.7.4 Argentina Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Estrogen and Progestin Extended-Release Patches Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Estrogen and Progestin Extended-Release Patches Sales, 2018-2029
6.8.3 Turkey Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.8.4 Israel Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.8.5 Saudi Arabia Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
6.8.6 UAE Estrogen and Progestin Extended-Release Patches Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Mylan Pharmaceuticals Inc.(Viatris)
7.1.1 Mylan Pharmaceuticals Inc.(Viatris) Company Summary
7.1.2 Mylan Pharmaceuticals Inc.(Viatris) Business Overview
7.1.3 Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Major Product Offerings
7.1.4 Mylan Pharmaceuticals Inc.(Viatris) Estrogen and Progestin Extended-Release Patches Sales and Revenue in Global (2018-2023)
7.1.5 Mylan Pharmaceuticals Inc.(Viatris) Key News & Latest Developments
7.2 Twirla
7.2.1 Twirla Company Summary
7.2.2 Twirla Business Overview
7.2.3 Twirla Estrogen and Progestin Extended-Release Patches Major Product Offerings
7.2.4 Twirla Estrogen and Progestin Extended-Release Patches Sales and Revenue in Global (2018-2023)
7.2.5 Twirla Key News & Latest Developments
7.3 Novartis(HEXAL AG)
7.3.1 Novartis(HEXAL AG) Company Summary
7.3.2 Novartis(HEXAL AG) Business Overview
7.3.3 Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Major Product Offerings
7.3.4 Novartis(HEXAL AG) Estrogen and Progestin Extended-Release Patches Sales and Revenue in Global (2018-2023)
7.3.5 Novartis(HEXAL AG) Key News & Latest Developments
7.4 Bayer Healthcare Pharmaceuticals
7.4.1 Bayer Healthcare Pharmaceuticals Company Summary
7.4.2 Bayer Healthcare Pharmaceuticals Business Overview
7.4.3 Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Major Product Offerings
7.4.4 Bayer Healthcare Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales and Revenue in Global (2018-2023)
7.4.5 Bayer Healthcare Pharmaceuticals Key News & Latest Developments
7.5 Noven
7.5.1 Noven Company Summary
7.5.2 Noven Business Overview
7.5.3 Noven Estrogen and Progestin Extended-Release Patches Major Product Offerings
7.5.4 Noven Estrogen and Progestin Extended-Release Patches Sales and Revenue in Global (2018-2023)
7.5.5 Noven Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Estrogen and Progestin Extended-Release Patches Major Product Offerings
7.6.4 AbbVie Estrogen and Progestin Extended-Release Patches Sales and Revenue in Global (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 Hisamitsu Pharmaceutical Co., Inc.
7.7.1 Hisamitsu Pharmaceutical Co., Inc. Company Summary
7.7.2 Hisamitsu Pharmaceutical Co., Inc. Business Overview
7.7.3 Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Major Product Offerings
7.7.4 Hisamitsu Pharmaceutical Co., Inc. Estrogen and Progestin Extended-Release Patches Sales and Revenue in Global (2018-2023)
7.7.5 Hisamitsu Pharmaceutical Co., Inc. Key News & Latest Developments
7.8 Watson Pharmaceuticals
7.8.1 Watson Pharmaceuticals Company Summary
7.8.2 Watson Pharmaceuticals Business Overview
7.8.3 Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Major Product Offerings
7.8.4 Watson Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales and Revenue in Global (2018-2023)
7.8.5 Watson Pharmaceuticals Key News & Latest Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Company Summary
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Estrogen and Progestin Extended-Release Patches Major Product Offerings
7.9.4 Johnson & Johnson Estrogen and Progestin Extended-Release Patches Sales and Revenue in Global (2018-2023)
7.9.5 Johnson & Johnson Key News & Latest Developments
7.10 ANI Pharmaceuticals
7.10.1 ANI Pharmaceuticals Company Summary
7.10.2 ANI Pharmaceuticals Business Overview
7.10.3 ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Major Product Offerings
7.10.4 ANI Pharmaceuticals Estrogen and Progestin Extended-Release Patches Sales and Revenue in Global (2018-2023)
7.10.5 ANI Pharmaceuticals Key News & Latest Developments
7.11 Zhejiang Yatai Pharmaceutical Company Ltd.
7.11.1 Zhejiang Yatai Pharmaceutical Company Ltd. Company Summary
7.11.2 Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Business Overview
7.11.3 Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Major Product Offerings
7.11.4 Zhejiang Yatai Pharmaceutical Company Ltd. Estrogen and Progestin Extended-Release Patches Sales and Revenue in Global (2018-2023)
7.11.5 Zhejiang Yatai Pharmaceutical Company Ltd. Key News & Latest Developments
8 Global Estrogen and Progestin Extended-Release Patches Production Capacity, Analysis
8.1 Global Estrogen and Progestin Extended-Release Patches Production Capacity, 2018-2029
8.2 Estrogen and Progestin Extended-Release Patches Production Capacity of Key Manufacturers in Global Market
8.3 Global Estrogen and Progestin Extended-Release Patches Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Estrogen and Progestin Extended-Release Patches Supply Chain Analysis
10.1 Estrogen and Progestin Extended-Release Patches Industry Value Chain
10.2 Estrogen and Progestin Extended-Release Patches Upstream Market
10.3 Estrogen and Progestin Extended-Release Patches Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Estrogen and Progestin Extended-Release Patches Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe